Anne-Kathrin advises strategic and financial investors on complex national and international private M&A transactions. She also assists clients with cross-border joint ventures and restructurings (e.g. carve-outs).
Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices
